Migraine. Migraine, unspecified
Conditions
Interventions
Intervention 1: Intervention group:vitamin D, 50000 IU, every week 1 supplement, 10 weeks. Intervention 2: Placebo group: placebo, every week 1 supplement, 10 weeks.
Treatment - Drugs
Placebo
Intervention group:vitamin D, 50000 IU, every week 1 supplement, 10 weeks
Placebo group: placebo, every week 1 supplement, 10 weeks
Sponsors
Research Deputy of Isfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
10 Years to 61 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: aged 10-61 years; confirmation of migraine by neurologist; desire to participate in present study; do not use of corticosteroids,OCP,vitamin D, magnesium,calcium and riboflavin; do not take of antimigraine drugs; lack of tension headaches. Exclusion criteria: having diseases of liver , kidney and primary hyperparathyroidism; hypervitaminosis D
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| C-reactive protein (CRP). Timepoint: First and end of intervention. Method of measurement: Laboratory analysis ( blood test).;Migraine symptoms ( severity , frequency and average duration of migraine attacks). Timepoint: first and end of intervention. Method of measurement: Questionaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactTayebeh Mottaghi
Isfahan university of medical sciences
Outcome results
None listed